MiR-106b-5p improving the progression of chronic kidney disease by inhibiting the TGF-β/Smad pathway
miR-106b-5p ameliorates CKD progression by suppressing the TGF - β/Smad signaling pathway and could potentially be a therapeutic target for CKD.
Authors
- Yong Li (ORCID: https://orcid.org/0000-0002-8910-9787)
- Peng Zhou (ORCID: https://orcid.org/0000-0002-9005-7507)
- Sun Danan (ORCID: https://orcid.org/0009-0001-2775-0755)
- Qiang Ma (ORCID: https://orcid.org/0000-0002-7477-1743)
- Lili Xu (ORCID: https://orcid.org/0000-0001-8759-1568)
Institutions
- Harbin University (CN)
- Heilongjiang University of Chinese Medicine (CN)
- First Affiliated Hospital of Heilongjiang University of Chinese Medicine (CN)
- Heilongjiang Provincial Hospital (CN)
Publication Details
- Journal
- Hereditas
- Published
- 2025-06-13
- DOI
- https://doi.org/10.1186/s41065-025-00468-7
- Citations
- 1
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- Natural Science Foundation of Heilongjiang Province